Friday, November 13, 2026

EUR/CHF Bearish Momentum: 0.86% Down In The Last 5 Sessions

Automated market report from our archive (2020–2024), published before source-traceability. How we work

EUR/CHF Bearish Momentum: 0.86% Down In The Last 5 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 0.86% for the last 5 sessions. At 16:07 EST on Friday, 19 July, EUR/CHF (EURCHF) is $0.97.

EUR/CHF's yearly highs and lows, it's 7.11% up from its 52-week low and 2.598% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy extends upside near 158.50 despite strong Japan’s tankan index. According to FXStreet on Wednesday, 17 July, "The USD/JPY pair extends gains near 158.40 on the selling pressure around the Japanese currency during the early Asian session on Wednesday. "
  • Usd/jpy price analysis: plummets below 157.00 as bears stepped in. According to FXStreet on Wednesday, 17 July, "On the other hand, if buyers stepped in and pushed the USD/JPY above 157.00, look for a re-test of the July 16 peak at 158.85.", "If USD/JPY clears the narrowest part of the Kumo sliding beneath 155.50/60, that would expose the May 16 swing low of 153.61. "
  • Usd/jpy price analysis: surges over 0.70% and reclaims 157.00. According to FXStreet on Thursday, 18 July, "On the other hand, if buyers stepped in and pushed the USD/JPY above 157.50, look for a re-test of the July 16 peak at 158.85.", "The US Dollar stages a comeback against the Japanese Yen and pushes the USD/JPY pair higher on Thursday, posting gains of more than 0.70% and reclaiming the 157.00 figure at the time of writing. "
  • According to FXStreet on Thursday, 18 July, "In the general weakness of the USD, the USD/JPY movement stood out in particular. ", "If USD/JPY is already sliding due to a bout of general USD weakness, a round of intervention seems promising because in a phase in which the market is searching for a new equilibrium based on new information, interventions change this search process."
  • According to FXStreet on Wednesday, 17 July, "Returning to trade within the ascending channel would likely improve sentiment for the USD/JPY pair, with a potential target toward the upper boundary of the channel near 164.00.", "On the downside, the USD/JPY pair could find key support around the psychological level of 158.00. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com